VIA Pharmaceuticals, Inc./ US92554T1034 /
2024-03-07 4:20:07 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 700 Turnover: .0007 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
05-15
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-15
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
GlobeNewswire
05-15
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corp...
GlobeNewswire
05-15
Investigation Alert Baxter International, Eagle Pharmaceuticals, BioXcel Therapeutics, and ImmunityB...
GlobeNewswire
05-15
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
GlobeNewswire
05-14
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Finan...
GlobeNewswire
05-14
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reviva Pharmaceuticals Holdings, Inc. Investors to...
GlobeNewswire
05-14
Design 1st and Swabbot Elevate Industrial Cleaning with Collaborative Robot Solution Engineered for ...
GlobeNewswire
05-14
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major...
GlobeNewswire
05-13
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals Wi...
GlobeNewswire
05-13
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (...
GlobeNewswire
05-10
Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building
GlobeNewswire
05-10
Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building
GlobeNewswire
05-09
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-09
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2...
GlobeNewswire
05-09
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire
05-08
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire
05-07
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia